[go: up one dir, main page]

DE602004007505D1 - Pioglitazonsulfat, pharmazeutische zusammensetzungen und deren anwendung - Google Patents

Pioglitazonsulfat, pharmazeutische zusammensetzungen und deren anwendung

Info

Publication number
DE602004007505D1
DE602004007505D1 DE602004007505T DE602004007505T DE602004007505D1 DE 602004007505 D1 DE602004007505 D1 DE 602004007505D1 DE 602004007505 T DE602004007505 T DE 602004007505T DE 602004007505 T DE602004007505 T DE 602004007505T DE 602004007505 D1 DE602004007505 D1 DE 602004007505D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
pioglitazone
pioglitazone sulfate
sulfate
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004007505T
Other languages
English (en)
Other versions
DE602004007505T2 (de
Inventor
Jie Zhu
Frantisek Picha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthon BV
Original Assignee
Synthon BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon BV filed Critical Synthon BV
Publication of DE602004007505D1 publication Critical patent/DE602004007505D1/de
Application granted granted Critical
Publication of DE602004007505T2 publication Critical patent/DE602004007505T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE602004007505T 2003-05-13 2004-05-13 Pioglitazonsulfat, pharmazeutische zusammensetzungen und deren anwendung Expired - Fee Related DE602004007505T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46983803P 2003-05-13 2003-05-13
US469838P 2003-05-13
PCT/EP2004/005133 WO2004101561A1 (en) 2003-05-13 2004-05-13 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same

Publications (2)

Publication Number Publication Date
DE602004007505D1 true DE602004007505D1 (de) 2007-08-23
DE602004007505T2 DE602004007505T2 (de) 2008-03-13

Family

ID=33452331

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004007505T Expired - Fee Related DE602004007505T2 (de) 2003-05-13 2004-05-13 Pioglitazonsulfat, pharmazeutische zusammensetzungen und deren anwendung

Country Status (12)

Country Link
US (2) US7230016B2 (de)
EP (1) EP1622899B1 (de)
JP (1) JP2006528948A (de)
AT (1) ATE366733T1 (de)
AU (1) AU2004238537A1 (de)
CA (1) CA2525316A1 (de)
DE (1) DE602004007505T2 (de)
ES (1) ES2290709T3 (de)
IL (1) IL171875A0 (de)
NO (1) NO20055830D0 (de)
WO (1) WO2004101561A1 (de)
ZA (1) ZA200509155B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7230016B2 (en) * 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
WO2005080387A2 (en) * 2004-02-20 2005-09-01 Synthon B.V. Processes for making pioglitazone and compounds of the processes
JP2008195625A (ja) * 2007-02-08 2008-08-28 Pharma Frontier Kk Ｇ蛋白質共役型レセプター抑制剤および医薬
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
NZ597381A (en) 2007-09-14 2013-03-28 Metabolic Solutions Dev Co Llc Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases
RU2010128019A (ru) * 2007-12-08 2012-01-20 Байер Шеринг Фарма Акциенгезельшафт (DE) Пероральная диспергируемая таблетка
JP5383123B2 (ja) * 2008-09-02 2014-01-08 株式会社トクヤマ ピオグリタゾン塩酸塩の製造方法
US20100060985A1 (en) 2008-09-09 2010-03-11 Fujifilm Corporation Method for producing polarizing plate, and automobile's windshield
TR201202048T2 (tr) * 2009-05-26 2012-04-24 Abdi̇ İbrahi̇m İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇@ Pioglitazon çözeltisi ile kaplanmış metformin.
RU2012130011A (ru) * 2009-12-15 2014-01-27 МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи Ppar-снижающие тиазолидиндионы и комбинации для лечения сахарного диабета и других нарушений обмена веществ
HUE038042T2 (hu) 2009-12-15 2018-09-28 Cirius Therapeutics Inc PPAR helyettesítõ tiazolidindion sók metabolikus betegségek kezelésére
WO2012153312A1 (en) 2011-05-11 2012-11-15 Ranbaxy Laboratories Limited Process for the purification of pioglitazone
WO2014046697A1 (en) * 2012-09-21 2014-03-27 Reoxcyn Discoveries Group, Inc. Cell for electrolyzing a liquid

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
FI91869C (fi) 1987-03-18 1994-08-25 Tanabe Seiyaku Co Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
ATE123278T1 (de) 1991-03-25 1995-06-15 Takeda Chemical Industries Ltd Verfahren zur herstellung von ethern.
JPH07138258A (ja) * 1993-11-16 1995-05-30 Taiho Yakuhin Kogyo Kk チアゾリジンジオン誘導体又はその塩
ATE235476T1 (de) * 1994-08-10 2003-04-15 Takeda Chemical Industries Ltd Thiazolidindione derivate, ihre herstellung und verwendung
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5814647A (en) * 1997-03-04 1998-09-29 Board Of Regents, The University Of Texas System Use of troglitazone and related compounds for the treatment of the climacteric symptoms
SE9702305D0 (sv) * 1997-06-17 1997-06-17 Astra Ab New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.
AU2002311057A1 (en) 2001-04-26 2002-11-11 Leciva, A.S. Method for obtaining pioglitazone as an antidiabetic agent
EP1622898A1 (de) * 2003-05-13 2006-02-08 Synthon B.V. Verfahren zur herstellung von thiazolidindion- derivaten und dazu gehörige verbindungen
US7230016B2 (en) * 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same

Also Published As

Publication number Publication date
US20070203199A1 (en) 2007-08-30
ZA200509155B (en) 2007-04-25
AU2004238537A1 (en) 2004-11-25
DE602004007505T2 (de) 2008-03-13
ES2290709T3 (es) 2008-02-16
EP1622899A1 (de) 2006-02-08
WO2004101561A1 (en) 2004-11-25
EP1622899B1 (de) 2007-07-11
US7230016B2 (en) 2007-06-12
JP2006528948A (ja) 2006-12-28
NO20055830L (no) 2005-12-08
CA2525316A1 (en) 2004-11-25
IL171875A0 (en) 2006-04-10
ATE366733T1 (de) 2007-08-15
US20050054684A1 (en) 2005-03-10
NO20055830D0 (no) 2005-12-08

Similar Documents

Publication Publication Date Title
CY2015009I2 (el) Ινδολινονες υποκατεστημενες στη θεση 6, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα
CY1120377T1 (el) Στερεη φαρμακευτικη δοσολογικη φαρμακοτεχνικη μορφη που περιεχει λοπιναβιρη
ATE366733T1 (de) Pioglitazonsulfat, pharmazeutische zusammensetzungen und deren anwendung
DE602004021904D1 (de) Gyraseinhibitoren und deren verwendungen
ITPD20020138A0 (it) Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.
DE602004015134D1 (de) Saugfähige artikel mit metallbeladenen nanoteilchen
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
CY1116554T1 (el) Αλατα κλοπιδογρελης και μεθοδος παρασκευης
TW200621268A (en) Antimicrobial copolymers and uses thereof
DE602004020907D1 (de) Benzimidazolderivate, zusammensetzungen, die diese enthalten, zubereitung davon und deren verwendungen
DE60307632D1 (de) Piperazinylacylpiperidinderivate, deren herstellung und deren therapeutische anwendung
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
DE60139195D1 (de) Aktivierbare polymerzusammensetzung, und gegenstände, die diese nutzen
ITFI20020038A1 (it) Coloranti ceramici in forma di sospensioni nanometriche
FR2846327B1 (fr) Derives de n-benzodioxolyl, n-benzodioxanyl et n-benzodioxepinyl arylcarboxamides utilisables dans le traitement de dyslipidemies et compositions pharmaceutiques les contenant.
DE602004016016D1 (de) Benzimidazolderivate, zusammensetzungen, die diese enthalten, zubereitung davon und deren verwendungen
DE602004014787D1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
DE602004016015D1 (de) Benzimidazolderivate, zusammensetzungen, die diese enthalten, zubereitung davon und deren verwendungen
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
DE602005012287D1 (de) Biotinylierte hexadecasaccharide, pharmazeutische zusammensetzungen daraus und deren verwendung
ITRM20020119A1 (it) Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
TR200706209T1 (tr) Alfuzosinin kontrollü salınım formülasyonları.
ATE438701T1 (de) 3-isopropyl-1-methylcyclopentylderivate und deren verwendung bei riechstoffanwendungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee